Skip to main content
. 2020 Apr 30;26(2):281–288. doi: 10.5056/jnm19050

Table 3.

Medical Costs of Gastroesophageal Reflux Disease Treatment in the Medication and Surgery Groups (Unit: Dollars)

Variables n A. Inpatient costs B. Outpatient costs C. PPI costs D. Other drug costs E. Follow-up months Total monthly costs (A + B + C + D)/E
Surgery group
Total 40 4591.7 (403.90) 232.4 (42.83) 37.7 (12.78) 200.0 (111.51) 6.7 (0.61) 1423.9 (259.22)
Number of days from surgery
≤ 90 40 4509.7 (390.74) 99.1 (19.57) 13.1 (4.26) 153.5 (110.67) 2.6 (0.11) 2071.6 (240.17)
> 90a 30 109.4 (109.42) 177.7 (48.37) 32.8 (14.22) 62.1 (23.41) 5.4 (0.51) 107.7 (59.99)
Medication group
Total 86 936 540.2 (10.24) 359.5 (7.24) 156.6 (0.36) 455.8 (2.47) 9.3 (0.01) 162.7 (1.35)
PDD of PPIs
< standard 76 182 513.2 (10.66) 348.4 (7.86) 148.3 (0.34) 450.8 (2.53) 9.3 (0.01) 158.1 (1.44)
standard to < double 10 195 702.7 (33.59) 426.0 (18.49) 213.9 (1.45) 495.6 (9.04) 9.4 (0.03) 191.7 (4.03)
≥ double 559 1251.3 (215.52) 658.0 (85.56) 235.4 (9.49) 412.5 (28.29) 9.5 (0.12) 254.6 (23.30)
a

Only subjects who passed 3 months after surgery in each year were analyzed.

PPI, proton pump inhibitor; PDD, prescribed daily dose.

Data are presented as mean (SE).